Compare W & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | W | RVTY |
|---|---|---|
| Founded | 2002 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.7B |
| IPO Year | 2014 | 1994 |
| Metric | W | RVTY |
|---|---|---|
| Price | $56.19 | $95.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 16 |
| Target Price | $105.82 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 3.8M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ 39.15 | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $7.39 | $6.37 |
| Revenue Next Year | $6.00 | $5.10 |
| P/E Ratio | ★ N/A | $266.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.46 | $81.22 |
| 52 Week High | $119.98 | $118.30 |
| Indicator | W | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 30.05 | 55.12 |
| Support Level | N/A | $94.57 |
| Resistance Level | $81.43 | $102.16 |
| Average True Range (ATR) | 3.61 | 4.01 |
| MACD | -0.78 | 0.22 |
| Stochastic Oscillator | 1.46 | 65.46 |
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 12 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.